Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: University of North Carolina-Chapel Hill: Development and Application of Biomarkers of Exposure

Superfund Research Program

Development and Application of Biomarkers of Exposure

Project Leader: Stephen M. Rappaport (University of California-Berkeley)
Grant Number: P42ES005948
Funding Period: 1995 - 2011

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Progress Reports

Year:   2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995 

Project investigators continue to make progress in the use of biomarkers to understand the complex human metabolism of benzene and other ubiquitous environmental carcinogens, notably naphthalene. A host of biomarkers is being applied in studies of benzene- and naphthalene-exposed populations, including protein adducts of several reactive metabolites of benzene and naphthalene, of benzene and naphthalene in breath and urine, and of benzene and naphthalene metabolites in urine. Using these biomarkers, they are evaluating the uptake and metabolism of benzene and naphthalene over a wide range of human exposures. Human biomarkers are measured in samples of blood, urine, and breath obtained in prior studies and by collaborators at other institutions. Benzene metabolites of interest include reactive intermediates, i.e., benzene oxide and 1,2- and 1,4-benzoquinone, as well as the following stable urinary products: phenol, catechol, hydroquinone, trihydroxybenzene, E,E-muconic acid and S-phenylmercapturic acid. The analogous naphthalene metabolites are naphthalene oxide, the naphthoquinones, and urinary naphthols. Project investigators have now developed assays for these biomarkers and have measured them in well over 1000 subjects exposed to benzene and/or naphthalene in a host of industrial populations (automobile mechanics, jet-fuel workers, shoe manufacturing workers, workers in industries using benzene as a solvent, coke-oven workers) as well as control populations. They are currently analyzing these data to explore the relationships between biomarkers and exposure to benzene and naphthalene and to determine effects of physiological and genetic factors on levels of biomarkers.

to Top